BMC Cardiovascular Disorders (Jul 2024)
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
- Fardad Soltani,
- David A. Jenkins,
- Amit Kaura,
- Joshua Bradley,
- Nicholas Black,
- John P. Farrant,
- Simon G. Williams,
- Abdulrahim Mulla,
- Benjamin Glampson,
- Jim Davies,
- Dimitri Papadimitriou,
- Kerrie Woods,
- Anoop D. Shah,
- Mark R. Thursz,
- Bryan Williams,
- Folkert W. Asselbergs,
- Erik K. Mayer,
- Christopher Herbert,
- Stuart Grant,
- Nick Curzen,
- Iain Squire,
- Thomas Johnson,
- Kevin O’Gallagher,
- Ajay M. Shah,
- Divaka Perera,
- Rajesh Kharbanda,
- Riyaz S. Patel,
- Keith M. Channon,
- Richard Lee,
- Niels Peek,
- Jamil Mayet,
- Christopher A. Miller
Affiliations
- Fardad Soltani
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester
- David A. Jenkins
- Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester
- Amit Kaura
- NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary’s Hospital
- Joshua Bradley
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester
- Nicholas Black
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester
- John P. Farrant
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester
- Simon G. Williams
- Manchester University NHS Foundation Trust
- Abdulrahim Mulla
- NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary’s Hospital
- Benjamin Glampson
- NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary’s Hospital
- Jim Davies
- NIHR Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals NHS Foundation Trust
- Dimitri Papadimitriou
- NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary’s Hospital
- Kerrie Woods
- NIHR Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals NHS Foundation Trust
- Anoop D. Shah
- London Biomedical Research Centre, NIHR University College, University College London and University College London Hospitals NHS Foundation Trust
- Mark R. Thursz
- NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary’s Hospital
- Bryan Williams
- London Biomedical Research Centre, NIHR University College, University College London and University College London Hospitals NHS Foundation Trust
- Folkert W. Asselbergs
- London Biomedical Research Centre, NIHR University College, University College London and University College London Hospitals NHS Foundation Trust
- Erik K. Mayer
- NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary’s Hospital
- Christopher Herbert
- NIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds
- Stuart Grant
- NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, University of Manchester
- Nick Curzen
- NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Faculty of Medicine, University of Southampton and University Hospital Southampton NHS Foundation Trust
- Iain Squire
- NIHR Biomedical Research Centre, Glenfield Hospital
- Thomas Johnson
- NIHR Bristol Biomedical Research Centre, University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust
- Kevin O’Gallagher
- King’s College London British Heart Foundation Centre of Excellence and King’s College Hospital NHS Foundation Trust
- Ajay M. Shah
- King’s College London British Heart Foundation Centre of Excellence and King’s College Hospital NHS Foundation Trust
- Divaka Perera
- British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, King’s College London
- Rajesh Kharbanda
- NIHR Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals NHS Foundation Trust
- Riyaz S. Patel
- London Biomedical Research Centre, NIHR University College, University College London and University College London Hospitals NHS Foundation Trust
- Keith M. Channon
- NIHR Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals NHS Foundation Trust
- Richard Lee
- NIHR Biomedical Research Centre, The Royal Marsden and Institute of Cancer Research
- Niels Peek
- Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester
- Jamil Mayet
- NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, St Mary’s Hospital
- Christopher A. Miller
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester
- DOI
- https://doi.org/10.1186/s12872-024-03987-9
- Journal volume & issue
-
Vol. 24,
no. 1
pp. 1 – 10
Abstract
Abstract Background Heart failure (HF) with preserved or mildly reduced ejection fraction includes a heterogenous group of patients. Reclassification into distinct phenogroups to enable targeted interventions is a priority. This study aimed to identify distinct phenogroups, and compare phenogroup characteristics and outcomes, from electronic health record data. Methods 2,187 patients admitted to five UK hospitals with a diagnosis of HF and a left ventricular ejection fraction ≥ 40% were identified from the NIHR Health Informatics Collaborative database. Partition-based, model-based, and density-based machine learning clustering techniques were applied. Cox Proportional Hazards and Fine-Gray competing risks models were used to compare outcomes (all-cause mortality and hospitalisation for HF) across phenogroups. Results Three phenogroups were identified: (1) Younger, predominantly female patients with high prevalence of cardiometabolic and coronary disease; (2) More frail patients, with higher rates of lung disease and atrial fibrillation; (3) Patients characterised by systemic inflammation and high rates of diabetes and renal dysfunction. Survival profiles were distinct, with an increasing risk of all-cause mortality from phenogroups 1 to 3 (p < 0.001). Phenogroup membership significantly improved survival prediction compared to conventional factors. Phenogroups were not predictive of hospitalisation for HF. Conclusions Applying unsupervised machine learning to routinely collected electronic health record data identified phenogroups with distinct clinical characteristics and unique survival profiles.
Keywords
- Heart failure with preserved or mildly reduced ejection fraction
- Machine learning
- Electronic health records